Dr. Brian Michael Brady, MD

Dr. Brady practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Brady's NPI, 1902190721, was assigned on June 9, 2011. Dr. Brady graduated from Sidney Kimmel Medical College in 2011. Dr. Brady holds California license A136657.

Dr. Brady's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Brady's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Brady is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Brady to 1 more hospital, 4 dialysis centers and 1 medical group, each named with a free account. Dr. Brady's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brady practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Brady's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Brady is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Brady's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts, kidney disease and parathyroid gland disorder among the conditions Dr. Brady treats.

CMS data shows 733 Medicare services from Dr. Brady across 9 procedure codes in 2024, for 421 Medicare patients. Medicare paid $81,825 for them.

CMS counts 421 Medicare patients who saw Dr. Brady in 2024. The largest group is 75 to 84, with 150 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brady's median patient age at 71, with 43% women.

In 2024, Dr. Brady wrote 1,042 Medicare Part D claims for 202 patients. 68% of them were for generic drugs. CMS names the drug for 843 of them, across 24 drugs with 11 or more claims each, at $274,035 in total drug cost. In 2023, CMS named 719 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Brady for performance year 2024, reported as part of a group. Dr. Brady accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brady as offering telehealth.

Dmand AI links 11 papers to Dr. Brady, published from 2018 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Kidney Failure, Chronic, Nephrologists and Renal Dialysis. Dr. Brady has published most often in Clin J Am Soc Nephrol. Dr. Brady's most frequent co-authors are Glenn Matthew Chertow, MD, Kevin Furman Erickson, MD and Wolfgang C. Winkelmayer, DSC, MD.

CMS Open Payments shows 9 general payments to Dr. Brady from 2 drug and device companies from 2023 to 2024. Travel and lodging make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,288.

Dr. Brady graduated from Sidney Kimmel Medical College in 2011.

Dr. Brady is in network with 9 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.